Efficacy and safety of rilmenidine for arterial hypertension.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  American Journal of Cardiology

• Publication date

  1988-02-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(88)90474-2PMID 2894168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males

  2004cited by this paper
• Initial therapy in hypertension: quality-of-life considerations.

  1987cited by this paper
• Rational therapies for hypertension. Is step 1 of stepped care archaic?

  1987cited by this paper
• Quality of life and its impact on hypertensive patients.

  1987cited by this paper
• Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.

  1986cited by this paper
• Antihypertensive therapy in evolution.

  1986cited by this paper
• Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.

  1986cited by this paper
• Long-term evaluations of therapeutic efficacy and safety of guanfacine.

  1986cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• Bistrifluoromethylaryl derivatives for drug analysis by gas chromatography electron capture negative ion chemical ionization mass spectrometry. Application to the measurement of (N-dicyclopropylmethyl)amino-2-oxazoline in plasma.

  1985cited by this paper
• Alpha2-Adrenoceptor Agonists in the Treatment of Hypertension

  1985cited by this paper
• Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist.

  1985cited by this paper
• Gas chromatographic negative ion mass spectrometric assay of 2-dicyclopropylmethylamino-2-oxazoline (S-3341), a new antihypertensive drug.

  1985cited by this paper
• Therapy of mild hypertension: an overview.

  1984cited by this paper
• The Australian therapeutic trial in mild hypertension.

  1984cited by this paper
• Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial.

  1983cited by this paper
• Our national obsession with potassium.

  1982cited by this paper
• Diuretic-induced ventricular ectopic activity.

  1981cited by this paper
• The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

  1980cited by this paper
• Hypokalaemia and diuretics: an analysis of publications.

  1980cited by this paper
• Propranolol in the treatment of essential hypertension.

  1977cited by this paper
• Letter: Immunotherapy for colorectal cancer.

  1976cited by this paper
• FRACTURE OF THE FEMORAL NECK.

  1964cited by this paper

• ITERIUM-klinischer Nutzen einer neuartigen antihypertensiven Behandlung

  2021influential citation
• Cyclopropyl scaffold: a generalist for marketed drugs.

  2020cites this paper
• Iterium: Clinical benefits from an innovative antihypertensive treatment

  2019cites this paper
• ITERIUM - klinischer Nutzen einer neuartigen antihypertensiven Behandlung

  2019cites this paper
• Iterium: Clinical benefits from an innovative antihypertensive treatment

  2017cites this paper
• Dose-effect relationship of rilmenidine after chronic administration

  2004cites this paper
• Pharmacokinetic/pharmacodynamic Assessment of Tolerance to Central Nervous System Effects of a 3 mg Sustained Release Tablet of Rilmenidine in Hypertensive Patients

  2004influential citation
• ITERIUM - klinischer Nutzen einer neuartigen antihypertensiven Behandlung

  2003influential citation
• [Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use].

  2003cites this paper
• Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.

  2003cites this paper
• Concentration‐effect relationships of two rilmenidine single‐dose infusion rates in hypertensive patients

  2002cites this paper
• The Chronic Effect of Rilmenidine on Heart Rate Variability in Patients with Mild Hypertension

  2002cites this paper
• Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.

  2002cites this paper
• Comparison of Oral and Oral Sustained-Release Rilmenidine in Healthy Volunteers and Correlation with In Vitro Sustained-Release Properties

  2001cites this paper
• I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.

  2000cites this paper
• Moxonidina: un nuevo simpaticolítico de acción central

  2000cites this paper
• Rilmenidine: The Imidazoline-1 Receptor Agonist

  2000cites this paper
• Rilmenidine: a clinical overview.

  2000cites this paper
• Drugs Acting on Imidazoline Receptors

  1999cites this paper
• Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.

  1999cites this paper
• Cardiac vagal effects of rilmenidine in the dog: comparison with clonidine.

  1997cites this paper
• Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: comparison with clonidine.

  1996cites this paper
• Imidazoline Receptor Agonist Drugs: A New Approach to the Treatment of Systemic Hypertension

  1996cites this paper
• I1 Agents: A New Approach to the Treatment of Hypertension

  1995cites this paper
• Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients.

  1994cites this paper
• Cardiac electrophysiological effects of rilmenidine, a novel antihypertensive agent, in the conscious dog: comparison with clonidine.

  1994cites this paper
• Long-term control of blood pressure by rilmenidine in high-risk populations.

  1994cites this paper
• Effects of Rilmenidine and Hydrochlorothiazide on Human Platelet α2-Adrenoceptors

  1993cites this paper
• Molecular studies of alpha‐2‐adrenoceptor and catecholamine‐insensitive imidazoline‐receptor binding sites using [3H]-rilmenidine in rat brain and kidney

  1993cites this paper
• [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].

  1991cites this paper
• Rilmenidine and vigilance. Review of clinical studies.

  1989cites this paper
• Rilmenidine: a novel antihypertensive agent.

  1989cites this paper
• Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.

  1989cites this paper
• Hypertension in the elderly.

  1989cites this paper